Charter of the Audit Committee of the Board of Directors of Barr Pharmaceuticals, Inc. As Modified and Adopted by the Board on May 16, 2007 1. PURPOSE The Audit Committee (the “Committee”) of the Board of Directors (the “Board”) of Barr Pharmaceuticals, Inc., a Delaware corporation (the “Company”), is a standing committee of the Board and is established pursuant to Article III, Section 9 of the Company’s By-laws. The Committee’s purpose is to: • Assist the Board’s oversight of: (i) the adequacy of the Company’s internal controls and financial reporting process and the reliability of the Company’s financial reports to the public; (ii) the Company’s compliance with legal and regulatory requirements and the Company’s compliance program; (iii) the Independent Auditor’s qualifications and independence; and (iv) the performance of the Company’s internal audit function and the Company’s Independent Auditor; and • Prepare the report required by the rules of the Securities and Exchange Commission (“SEC”) to be included in the Company’s annual proxy statement. The Committee shall also assist the Board in providing oversight as to the Company’s financial and related activities, including capital market transactions and risk management. It is the objective of the Committee to maintain free and open means of communications among the Board, the Independent Auditor, the internal auditor and the financial and senior management of the Company. ...